DCHS2 (dachsous cadherin-related 2) is a calcium-dependent cell-adhesion protein that plays critical roles in development and disease through regulation of cellular morphogenesis and differentiation. DCHS2 functions in partnership with Fat protocadherins to control polarized cell-cell intercalation during craniofacial development, coordinating cartilage differentiation through Sox9 regulation 1. The protein is essential for normal hypothalamic-pituitary development, with DCHS2 deficiency causing anterior pituitary hypoplasia and infundibular defects in mouse models 2. In cardiac tissue, DCHS2 acts as a molecular switch determining pathological versus physiological cardiac growth - overexpression promotes pathological hypertrophy and impaired regeneration, while deletion induces beneficial physiological hypertrophy and cardiomyogenesis through Hippo/Yap1 signaling modulation 3. DCHS2 variants are associated with multiple human conditions including facial morphology variation 4, bone metabolism affecting compressive strength and lean mass 5, cognitive impairment and Alzheimer's disease 6, epilepsy susceptibility 7, and pituitary developmental defects 2. Additionally, frameshift mutations in DCHS2 occur specifically in microsatellite-unstable gastric and colorectal cancers, potentially disrupting cell adhesion functions 8. These findings establish DCHS2 as a multifunctional developmental regulator with significant clinical implications.